Bittium Wireless Oy of Oulu at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Bittium Wireless Oy

Ritaharjuntie 1, 90590 Oulu
Finland

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 9): stand C15

Fairground map

MEDICA 2021 fairground map: Hall 9

Our range of products

Product categories

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.01  Diagnostics
  • 01.01.06  Neurological diagnosis, apparatus and instruments

Neurological diagnosis, apparatus and instruments

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.01  Diagnostics
  • 01.01.07  Apparatus for sleep studies

Apparatus for sleep studies

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.01  Diagnostics
  • 01.01.13  Other diagnostic equipment

Other diagnostic equipment

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.11  Other equipment for electromedicine / medical technology

Other equipment for electromedicine / medical technology

  • 06  IT systems and IT solutions
  • 06.02  mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI)

mHealth, mobile IT, wireless technologies (Bluetooth, WI-FI)

  • 06  IT systems and IT solutions
  • 06.04  eHealth, telemedicine / telematics / telemetry

eHealth, telemedicine / telematics / telemetry

  • 06  IT systems and IT solutions
  • 06.05  Administrative information systems / software
  • 06.05.01  Healthcare information systems / software (HIS)

Healthcare information systems / software (HIS)

  • 06  IT systems and IT solutions
  • 06.06  Medical information systems / software
  • 06.06.02  Internet / web portals, healthcare portals

Internet / web portals, healthcare portals

Our products

Product category: Other diagnostic equipment

Bittium Faros™

Bittium Faros™ is a versatile waterproof ECG device that is used for early detection of arrhytmias in everyday life. Bittium Faros is ultra-small and lightweight, which enables precise full disclosure ECG measurements for long-term Holtering, cardiac event monitoring, mobile cardiac telemetry and assessing autonomic nervous system functions. Bittium Faros outpatient monitoring solutions include several software options for cardiac monitoring. The built-in arrhythmia detection algorithms on the Bittium Faros device are used for event recording and cardiac event monitoring. Bittium's solutions enable the earlier discharge of patients and the ability to react to detected arrhythmias faster.

More Less

Product category: Healthcare information systems / software (HIS)

Bittium Cardiac Navigator™

Bittium Cardiac Navigator™ is a completely new type of solution for the analysis of clinical Holter ECG recordings. Its user-friendly and informative data presentation and intuitive analysis tools make the software efficient and easy to use when analyzing multiple days of ECG recordings. Bittium Cardiac Navigator is designed for scanning longer measurements efficiently in a shorter time and thus speeding up the final diagnosis.

More Less

Product category: eHealth, telemedicine / telematics / telemetry

Bittium HolterPlus™

Bittium HolterPlus™ is a web-based remote cardiac monitoring solution for private cardiologists, cardiac service providers, hospitals and clinics. Bittium HolterPlus™ bridges the gap between a Holter and implantable monitoring device by providing the possibility of extending the duration of a cardiac monitoring session. The components of this solution are the Bittium Faros™ ECG recorder, a Bittium MedicalSuite™ mobile device, and access to the web portal.

More Less

Product category: Internet / web portals, healthcare portals

Bittium MedicalSuite™

Bittium MedicalSuite™ is an advanced web-based remote monitoring service platform that facilitates secure information sharing between service providers, clinics and cardiologists to enable better collaborative care. The Service is a combination of intelligent analysis, wireless data transfer, reporting and management modules which can be optimized according to your needs. As a result, you can benefit from effortless workflows and enhanced efficiency.

More Less

Product category: Neurological diagnosis, apparatus and instruments

Bittium BrainStatus™

Bittium BrainStatus™ product family is a compact wireless EEG measurement system for the brain's real-time electrical activity monitoring. It is designed for emergency, acute and intensive care use. Its ease of use enables high-quality EEG measurements by both paramedics and clinicians quickly and easily.

Bittium BrainStatus™ product family consists of a wireless compact EEG amplifier, EEG measurement software, and a disposable electrode headband that is quick to wear below the hairline. Bittium BrainStatus can be used for real-time remote EEG monitoring for patients with altered levels of consciousness e.g. epileptic seizures or detecting effects of brain hypoxia.  The system enables quick measurements also in field conditions. Remote diagnosis can be done regardless of the patient's or clinician's location, which makes the treatment process faster for the patient.

More Less

Product category: Neurological diagnosis, apparatus and instruments

Bittium NeurOne™

Bittium NeurOne™ is one of the quickest and most accurate EEG measuring devices in the world designed for clinical and research use. Bittium NeurOne system enables fully synchronized group measuring of up to 30 persons simultaneously for example in different types of psychological studies. The solution is optimized for use with transcranial magnetic stimulators (TMS-EEG), with optional possibility to use it during magnetic resonance imaging procedures (fMRI-EEG).

More Less

Product category: Apparatus for sleep studies

Bittium Respiro™

Bittium Respiro™ is a modern sleep apnea screening device and analysis service solution for service providers, hospitals, clinics, and health centers. It is focused on Home Sleep Apnea Testing (HSAT) and intended to record standard PG level data and analyze typical sleep related breathing disorders, such as obstructive sleep apnea, central sleep apnea, mixed sleep apnea, hypopnea and Cheyne-Stokes breathing.

Bittium Respiro™ is a medical device with functionality based on the latest technologies and widely accepted and investigated methods. Reliability, data security, and patient safety are our top priority and in the core of Bittium's know-how.

Disclaimer: Bittium Respiro™ is designed to be compliant with Medical Devices Regulation (MDR). Not yet available as a commercial product. Not available in the US.

More Less

Company news

Date

Topic

01 Sep 2021

Bittium Expands Its Minority Holdings in Remote Cardiology Service Companies in Europe

Bittium to purchase a 25 percent stake in a British company Technomed Limited

Oulu, Finland, September 1, 2021 – Bittium Biosignals Ltd, a subsidiary of Bittium Corporation, and British ECG service provider, Technomed Limited, have today signed an agreement under which Bittium will purchase a 25 percent stake in Technomed’s capital stock. The agreement will strengthen the partnership between the companies in the development of ECG technology that measure the electrical activity of the heart. This agreement will see Bittium's technology cooperation with European companies providing remote cardiology services expand. Bittium also has minority holdings in Swiss remote medical diagnostic services company evismo, and Coronaria Analyysipalvelut Ltd, a Finnish provider of ECG, sleep apnea and blood pressure analysis services.

Technomed Limited, trading as ECG On-Demand™, is an ECG service provider founded in 2001. The company has grown into one of the largest providers of ECG services in the United Kingdom. Technomed’s customers include NHS (National Healthcare Service) Trusts, private healthcare providers and cardiologists. Technomed has been using Bittium Faros™ ECG monitoring devices in its service offering for several years. The parties have agreed that the intensified cooperation will result in the use of other Bittium medical products and technologies via additional service offerings by ECG On-Demand™.

”We are very pleased to have the opportunity to deepen our technology cooperation with our long-term partner Technomed. Technomed has a prime market position and a growing customer base in the UK medical services market. Bittium’s aim is to be a significant international supplier of monitoring and remote diagnostics technology solutions made for measuring and analyzing biosignals, and the partnership agreement signed today is a part of the strategic actions toward this goal. The partnership agreement, combined with Bittium’s over 35 years of technical expertise in measuring and monitoring biosignals and analysis software development, provides us with a good foundation for developing the required technology for medical service business together”, tells Arto Pietilä, Senior Vice President of Bittium Medical Technologies.

“Bittium is an important technology provider for us, and we are pleased this partnership agreement and strengthened cooperation will bring continuity and long-term stability to the benefit of all parties, including our customers. ECG-On-Demand™ is an independent, profitable, and regulatory compliant diagnostic testing facility (IDTF), specializing in remote 12-lead ECG interpretation and point-of-care or mail-order wearable ambulatory ECG-Holter monitoring. We are also one of the few ECG-Holter monitoring services operating in the UK who have been inspected and rated by the UK Healthcare regulator (Care Quality Commission) and approved by NHS Digital”, says Mark Hashemi, the founder and CEO of Technomed.

The investment will be carried out as a share purchase, where Bittium will buy 25% of Technomed’s capital stock. The acquisition will be carried out when the technical conditions of the transaction are met. The share purchase does not change Bittium's financial outlook for the year 2021, published in Bittium Corporation Half Year Business Review on August 6, 2021. The parties have agreed not to publish the selling price.

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 (0)40 344 3507
 

Distribution:
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

Technomed

Technomed is a UK CQC inspected healthcare provider that uses a hybrid approach of Machine Learning (A.I.) and human expertise to deliver high-end arrhythmia diagnostic testing at point-of-care or by mail-order facility.  The first NHS Digital assured, HSCN connected ECG monitoring service that affords customers flexible and interchangeable service solutions that meet the challenges of diagnostic delivery in today’s changing healthcare landscape. www.ecg-od.com

More Less

25 Mar 2021

Bittium Expands Its Offering to Home Sleep Apnea Testing Solutions


Bittium Respiro™ is a modern sleep apnea testing device and analysis service solution intended to record polygraphy (PG) level data and analyze typical sleep-related breathing disorders

Oulu, Finland, March 25, 2021 – Bittium, a leading specialist for secure communications, connectivity, and medical technology solutions, expands its offering to Home Sleep Apnea Testing (HSAT) solutions. Bittium Respiro™ is a modern sleep apnea screening device and analysis service solution for service providers, hospitals, clinics, and health centers. It is focused on Home Sleep Apnea Testing (HSAT) and it is intended to record PG level data and analyze typical sleep-related breathing disorders. Bittium Respiro™ is compliant with Medical Devices Regulation (MDR) and will be available to the market in Q3/2021.

Sleep apnea is a serious medical condition, and if left untreated, it is associated with an array of adverse health consequences, including cardiovascular disease, metabolic disorders, diabetes, cognitive impairment, and depression. The most common type of sleep-disordered breathing is obstructive sleep apnea (OSA), and according to JCSM's studyi, the treatment has been shown to reduce the risk of the chronic health consequences, improve quality of life and lower the rates of motor vehicle accidents. The diagnosis of sleep apnea, however, is often a challenge. So far, sleep laboratories have often been the only option for patients. Modern medical technology can help addressing the diagnostic challenge.

"Bittium has over 35 years of experience in measuring and monitoring biosignals in the areas of cardiology and neurophysiology. Expanding our expertise to new diagnostic solutions is a natural step forward. We have put considerable efforts to the development of our home sleep apnea testing solution, and as a result, we are proud to provide a first sneak-preview for Bittium Respiro™, which is an impressive combination of a measuring device, analysis software and service platform," says Arto Pietilä, Senior Vice President of Bittium Medical Technologies.   

A New Level of Reliability, Safety, and Comfort for Home Sleep Apnea Testing

Bittium Respiro's functionalities are based on the latest technologies and widely accepted and investigated methods, such as American Academy of Sleep Medicine (AASM) guidelinesii. Reliability, data security, and patient safety are top priority and in the core of Bittium's know-how. Small size, wireless connectivity and one button usage make the device easy and comfortable for the patients. Modern printed electronics have been utilized in the electrical connection between the sensors and the device. This is also a hygienic and safe solution for the patient.

Bittium Respiro Analyst™ software provides a web-based intuitive user interface which utilizes artificial intelligence to accelerate analysis work. The software pre-analyses the massive amount of measurement data and converts it to a more visual and informative format. This makes it easier and quicker for healthcare personnel to perform further analysis and diagnosis. Bittium MedicalSuite™ provides the same cloud backend system for all Bittium medical products and services and enables fast and location independent data analysis.  

Bittium Respiro™ supports different business models and adapts flexibly to varying measurement needs. For example, it is suitable for clinics making quick analyses, where the cost of one measurement is an important factor. A more extensive measurement provides sleep specialists with more biosignals for demanding analyses. Bittium Respiro™ solution complies with AASM Type III guidelines and thus meets the criteria for reimbursement in most countriesiii.  

For more information about Bittium Respiro™, please visit: https://www.bittium.com/medical/bittium-respiro

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 (0)40 3443507
 

Distribution:

Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2020 were EUR 78.4 million and operating profit was EUR 2.1 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

iJournal of Clinical Sleep Medicine, https://jcsm.aasm.org/doi/10.5664/jcsm.6506, published Online: March 15, 2017
iiCompliant with American Academy of Sleep Medicine (AASM) Guidelines
iiiCountry-specific regulations need to be revised

More Less

20 Jan 2021

The Next Generation Bittium OmegaSnap™ ECG Electrode Enables Long-term ECG Recordings

Oulu, Finland, January 20, 2021 – Bittium, a leading specialist for secure communications, connectivity, and medical technology solutions, launches next-generation Bittium OmegaSnap™ ECG Electrode for the Bittium Faros™ ECG sensors. Bittium OmegaSnap™ is a wearable ECG patch electrode specifically designed for long term ECG recordings. The new electrode is based on the popular Bittium FastFix™ electrode, which has been further developed into an even more user-friendly shape based on the feedback received from our customers, without compromising the excellent signal quality. Additionally, environmental friendliness has been taken into account in the design by reducing the amount of plastic used in an electrode.

Bittium OmegaSnap™ ECG Electrode connects to the Bittium Faros™ sensor through a new reusable Bittium OmegaSnap™ Adapter. The lightweight and discreet adapter makes it easier to place the electrode on a patient without a Faros sensor attached to it. The adapter also allows the Faros sensor to be temporarily detached from the patch electrode. In the case of remote monitoring, such as the Bittium HolterPlus™ solution, it significantly enhances the long-term use of the sensor, for example, when charging.

The biocompatible materials and adhesives used in the new Bittium OmegaSnap™ electrode are commonly used in the healthcare industry, making the patches well suited for continuous long-term ECG measurements (up to 7 days). The electrode's flexible structure allows for larger chest movements and moving freely during sleep, daily chores, or when exercising.

"We are extremely proud of our new OmegaSnap™ electrode," says Arto Pietilä, Senior Vice President of Bittium Medical Technologies.  "Excellent anatomical fit and signal quality, extended wear time, and improved usability will take ECG measurements to a whole new level."

Bittium OmegaSnap™ ECG Electrode will be available during the first quarter of 2021. The sales package contains 50 Bittium OmegaSnap™ electrodes and one Bittium OmegaSnap™ adapter. The adapters are also available separately as accessories. For more information, please contact our sales at medical@bittium.com or from our website at www.bittium.com/medical .

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 (0)40 3443507
 

Distribution:

Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 35 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health, and sports medicine. Net sales in 2019 were EUR 75.2 million, and operating profit was EUR 6.3 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com

More Less

About us

Company data

Sales volume 50-99 Mio US $
Number of employees 500-999
Foundation 1985
Area of business
  • Imaging and diagnostics / medical equipment and devices
  • Diagnostic tests
  • IT systems and IT solutions